Team:Imperial College London/test10

From 2011.igem.org

Revision as of 15:01, 21 September 2011 by Yuanwei (Talk | contribs)




Module 1: Phyto-Route

Chemotaxis is the movement of bacteria based on attraction or repulsion of chemicals. Roots secrete a variety of compounds that E. coli are not attracted to naturally. Accordingly, we engineered a chemoreceptor into our chassis that can sense malate, a common root exudate, so that it can swim towards the root. Additionally, E. coli are actively taken up by plant roots, which will allow targeted IAA delivery into roots by our system.






Assembly

Fig. 1: Assembly strategy for our Phyto-Route construct.


We ordered both the PA2652 coding sequencs as two fragments to minimise cost and time (fig. 1). We did not want to use PCR to amplify the fragments in order to avoid introducing mutations into our final construct, and so we engineered blunt end cut sites on either side of our synthesized sequences with the MlyI restriction enzyme. Mly1 (type II restriction enzyme) cuts bluntly, 5 bp away from the recognition site. This property allowed us to cut out only the coding sequence of each fragment. Each digested fragment was then gel extracted to prepare for assembly.

The pSB1C3 vector was simultaneously inverse PCR'd to amplify the backbone vector with the required overlaps.

We planned to combine the two fragments into the pSB1C3 vector by Gibson assembly, unfortunately our attempts failed, we postulate that this was due to homology on the backbone vector, causing it to re-anneal.

We reverted to CPEC to assemble the construct, a method that requires more extensive use of PCR than Gibson. This said, by introducing MlyI restrictin sites, we were able to halve the number of PCR steps required, thereby reducing the potential mutation rate.


DNA was mini-prepped from colonies and sequenced by Eurofins. The sequences came back positive so we could move on and start characterizing the PA2652 construct.

Fig 2. Schematic of the final construct. Click on the parts to be directed to the registry.

The second fragment of our codon optimised mcpS receptor has still not arrived and therefore could not be assembled. However Juan L. Ramos of Consejo Superior de Investigaciones Científicas in Spain was able to provide us with non-codon optimised mcpS gene with unknown promoter and ribosome binding site in the pRK415 vector. We have pereformed chemotaxis assays on this construct as well.